Diadenosines as FHIT‐ness instructors
暂无分享,去创建一个
M. Campiglio | S. Ménard | G. Sozzi | F. Andriani | L. Roz | E. Tagliabue | F. Bianchi
[1] G. Sozzi,et al. Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer. , 2006, Neoplasia.
[2] K. Huebner,et al. Fhit and CHK1 have opposing effects on homologous recombination repair. , 2005, Cancer research.
[3] Y. Pekarsky,et al. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency. , 2005, Cancer research.
[4] L. D. Barnes,et al. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms. , 2005, Biochemistry.
[5] K. Huebner,et al. Involvement of the Fhit gene in the ionizing radiation‐activated ATR/CHK1 pathway , 2005, Journal of cellular physiology.
[6] G. Giaccone,et al. The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression , 2004, Oncogene.
[7] C. Croce,et al. Inactivation of the FHIT Gene Favors Bladder Cancer Development , 2004, Clinical Cancer Research.
[8] G. Sozzi,et al. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line , 2004, Oncogene.
[9] C. Croce,et al. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant , 2004, British Journal of Cancer.
[10] C. Croce,et al. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice , 2004, British Journal of Cancer.
[11] J. Minna,et al. Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.
[12] T. Pawełczyk,et al. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit. , 2004, Archives of biochemistry and biophysics.
[13] L. D. Barnes,et al. Fhit is a physiological target of the protein kinase Src. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. Croce,et al. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses. , 2004, Current gene therapy.
[15] T. Pawełczyk,et al. Distribution of Fhit protein in rat tissues and its intracellular localization , 2001, Molecular and Cellular Biochemistry.
[16] G. Gabriëls,et al. Vasoactivity of diadenosine polyphosphates in human small renal resistance arteries. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] A. Dejean,et al. Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.
[18] K. Sano,et al. Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases. , 2003, European journal of biochemistry.
[19] B M Stavrou. Diadenosine polyphosphates: postulated mechanisms mediating the cardiac effects. , 2003, Current medicinal chemistry. Cardiovascular and hematological agents.
[20] A. Vartanian. Gelsolin and plasminogen activator inhibitor-1 are Ap3A-binding proteins. , 2003, The Italian journal of biochemistry.
[21] C. Croce,et al. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Pintor,et al. Presence of Diadenosine Polyphosphates in the Aqueous Humor: Their Effect on Intraocular Pressure , 2003, Journal of Pharmacology and Experimental Therapeutics.
[23] Y. Pekarsky,et al. FHIT: from gene discovery to cancer treatment and prevention. , 2002, The Lancet. Oncology.
[24] A. Sillero,et al. Dinucleoside polyphosphates stimulate the primer independent synthesis of poly(A) catalyzed by yeast poly(A) polymerase. , 2002, European journal of biochemistry.
[25] Ann Janssen,et al. Vasoactivity of diadenosine polyphosphates in human small mesenteric resistance arteries. , 2002, The Journal of pharmacology and experimental therapeutics.
[26] Charles Brenner,et al. Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. , 2002, Biochemistry.
[27] C. Croce,et al. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Croce,et al. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. , 2001, JAMA.
[29] D. Roymans,et al. P2YAC−‐receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen‐activated protein kinase , 2001 .
[30] C. Croce,et al. The tumor spectrum in FHIT-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Sheridan,et al. Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates. , 2001, The Journal of pharmacology and experimental therapeutics.
[32] E. Rosato,et al. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. , 2001, Cancer research.
[33] C. Croce,et al. FHIT gene therapy prevents tumor development in Fhit-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] C. Croce,et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. , 2001, Cancer research.
[35] D. Roymans,et al. P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase. , 2001, British journal of pharmacology.
[36] J. Pintor,et al. Presence of diadenosine polyphosphates in human tears , 2001, Pflügers Archiv.
[37] A. McLennan. Dinucleoside polyphosphates-friend or foe? , 2000, Pharmacology & therapeutics.
[38] J. Pintor,et al. Diadenosine polyphosphate receptors. from rat and guinea-pig brain to human nervous system. , 2000, Pharmacology & therapeutics.
[39] A. Guranowski. Specific and nonspecific enzymes involved in the catabolism of mononucleoside and dinucleoside polyphosphates. , 2000, Pharmacology & therapeutics.
[40] K. Huebner,et al. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. , 2000, Cancer research.
[41] D. Notterman,et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.
[42] C. Brenner,et al. Fhit-nucleotide Specificity Probed with Novel Fluorescent and Fluorogenic Substrates* , 2000, The Journal of Biological Chemistry.
[43] M. Paterson,et al. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. , 2000, The Biochemical journal.
[44] A. Guranowski,et al. Selective degradation of 2'-adenylated diadenosine tri- and tetraphosphates, Ap(3)A and Ap(4)A, by two specific human dinucleoside polyphosphate hydrolases. , 2000, Archives of biochemistry and biophysics.
[45] C. Croce,et al. Muir-Torre-like syndrome in Fhit-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] Y. Pekarsky,et al. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. , 1999, Cancer research.
[47] C. Croce,et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Minna,et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. , 1999, Cancer research.
[49] C. Croce,et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. , 1998, Cancer research.
[50] B. Soria,et al. Intracellular diadenosine polyphosphates: a novel second messenger in stimulus‐secretion coupling , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] D. Beer,et al. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. , 1998, Cancer research.
[52] Y. Pekarsky,et al. Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] L. D. Barnes,et al. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Wolfson,et al. Diadenosine oligophosphates (Ap n A), a novel class of signalling molecules? , 1998, FEBS letters.
[55] P. Plateau,et al. Control of 5′,5′-Dinucleoside Triphosphate Catabolism by APH1, a Saccharomyces cerevisiaeAnalog of Human FHIT , 1998, Journal of bacteriology.
[56] L. D. Barnes,et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[57] L. D. Barnes,et al. Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein. , 1997, Protein engineering.
[58] A. Vartanian,et al. Opposite effects of cell differentiation and apoptosis on Ap3A/Ap4A ratio in human cell cultures , 1997, FEBS letters.
[59] A. Terzic,et al. Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel. , 1997, Biochemical pharmacology.
[60] L. D. Barnes,et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.
[61] Motonao Nakamura,et al. Functional coupling of adenosine A2a receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells. , 1996, The Biochemical journal.
[62] S. Edwards,et al. The diadenosine polyphosphates Ap3A and Ap4A and adenosine triphosphate interact with granulocyte-macrophage colony-stimulating factor to delay neutrophil apoptosis: implications for neutrophil: platelet interactions during inflammation. , 1996, Blood.
[63] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[64] J. Vishwanatha,et al. Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein. , 1995, Biochemistry.
[65] M. Maa,et al. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[66] J. Vishwanatha,et al. Characterization of the HeLa cell DNA polymerase alpha-associated Ap4A binding protein by photoaffinity labeling. , 1994, Biochemistry.
[67] T. Merkulova,et al. P1, P3‐bis(5′‐adenosyl)triphosphate (Ap3A) as a substrate and a product of mammalian tryptophanyl‐tRNA synthetase , 1994, FEBS letters.
[68] D. Volkin,et al. Interaction of nucleotides with acidic fibroblast growth factor (FGF-1). , 1994, Biochemistry.
[69] J. Estrela,et al. Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP. , 1994, The Biochemical journal.
[70] A. Wolfson,et al. Aminoacyl-tRNA synthetases from higher eukaryotes. , 1994, Progress in nucleic acid research and molecular biology.
[71] P. Plateau,et al. Dinucleoside oligophosphates in micro-organisms. , 1994, Advances in microbial physiology.
[72] E. Fuge,et al. AppppA-binding protein E89 is the Escherichia coli heat shock protein ClpB , 1993, Journal of bacteriology.
[73] J. Jackson,et al. Inhibition of bovine retinal microvascular pericyte proliferation in vitro by adenosine. , 1992, The American journal of physiology.
[74] P. Plateau,et al. In vivo synthesis of adenylylated bis(5'-nucleosidyl) tetraphosphates (Ap4N) by Escherichia coli aminoacyl-tRNA synthetases. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[75] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[76] P. Plateau,et al. Zinc-dependent synthesis of various dinucleoside 5',5' ' '-P1,P3-Tri- or 5'',5' ' '-P1,P4-tetraphosphates by Escherichia coli lysyl-tRNA synthetase. , 1982, Biochemistry.
[77] E. Holler,et al. Mechanism of synthesis of adenosine(5')tetraphospho(5')adenosine (AppppA) by aminoacyl-tRNA synthetases. , 1982, European journal of biochemistry.
[78] M. Stephenson,et al. Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase. , 1966, Biochemical and biophysical research communications.